Results 11 to 20 of about 2,709,028 (238)

Interleukin-35 as a key immunoregulatory mediator in steroid-hyporesponsive severe asthma [PDF]

open access: yesFrontiers in Immunology
Severe asthma remains a major unmet clinical challenge, largely due to corticosteroid hyporesponsiveness in a subset of patients. Despite high-dose inhaled or systemic corticosteroids and targeted biologics, chronic airway inflammation often persists ...
Jehan Al-Matouq   +10 more
doaj   +2 more sources

Association Between Interleukin 35 Gene Single Nucleotide Polymorphisms and the Uveitis Immune Status in a Chinese Han Population [PDF]

open access: yesFrontiers in Immunology, 2021
Autoimmune uveitis is characterized by immune disorders of the eyes and the whole body and is often recurrent in young adults, but its pathogenesis is still unclear.
Meng Feng   +13 more
doaj   +2 more sources

Interleukin-35 and Thymoquinone nanoparticle-based intervention for liver protection against paracetamol-induced liver injury in rats. [PDF]

open access: yesSaudi J Biol Sci, 2023
Paracetamol (PAR) is a commonly used antipyretic and analgesic agent, but its excessive usage can induce liver damage and major health consequences.
Abduh MS   +6 more
europepmc   +2 more sources

Expression of interleukin-35 and type 2 cytokines in children with acute allergic asthma [PDF]

open access: yesIranian Journal of Immunology, 2021
Background: Allergic asthma is believed to be a T helper 2 cell (Th2) preponderant response caused by airway hyper-responsiveness. Interleukin-35 (IL-35) is a newly discovered anti-inflammatory cytokine.
Zhangqiao Cai, Xuxia He, Jing Yang
doaj   +1 more source

Interleukin-35 Levels in Patients with Stable Coronary Artery Disease

open access: yes, 2022
Background It has been shown that interleukin-35 (IL-35) subunits are strongly expressed in atherosclerotic plaques in humans. Therefore, it is considered to play a role in atherosclerosis. Objectives In this study, IL-35 levels were compared with the
Bulent Demir (12698615)   +7 more
core   +1 more source

Interleukin-35 Suppresses Interleukin-9-Secreting CD4+ T Cell Activity in Patients With Hepatitis B-Related Hepatocellular Carcinoma

open access: yesFrontiers in Immunology, 2021
Chronic hepatitis B virus (HBV) infection induces dysfunction of immune response and chronic liver damage. However, the mechanisms that account for HBV-related hepatocellular carcinoma (HCC) are poorly understood.
Qian Zhang   +4 more
doaj   +1 more source

Increased Interleukin-35 suppresses peripheral CD14+ monocytes function in patients with Kawasaki disease

open access: yesBMC Immunology, 2020
Background Interleukin-35 (IL-35) is a newly identified IL-12 cytokine family member, which regulates the activity of immune cells in infectious diseases and autoimmune disorders.
Haijian Xing, Gang Tian
doaj   +1 more source

Effect of nonsurgical periodontal therapy on interleukin-35 level in gingival crevicular fluid

open access: yesSRM Journal of Research in Dental Sciences, 2023
Background: Clinical attachment level (CAL), alveolar bone loss, and periodontal pockets constitute the major signs of periodontitis. The interaction between the host and the bacteria that forms a biofilm on the tooth surface is one of the major ...
Ashwini Jadhav   +3 more
doaj   +1 more source

Impact of angiotensin converting enzyme inhibition on post- coronary artery bypass interleukin 6 release [PDF]

open access: yes, 2002
Background: Angiotensin 1 converting enzyme (ACE) inhibitors reduce morbidity and mortality after coronary artery bypass graft surgery (CABG). This benefit may result from an anti- inflammatory action.
Humphries, S.E.   +5 more
core   +8 more sources

Home - About - Disclaimer - Privacy